Cerebral Therapeutics

OverviewSuggest Edit

Cerebral Therapeutics is a clinical-stage pharmaceutical company dedicated to improving the lives of patients with uncontrolled neurological diseases, with an initial focus on refractory epilepsy. The Company utilizes long-term implanted brain drug-device combination therapies to deliver optimal doses of specially formulated anti-seizure medications directly to the target region of the brain. Cerebral Therapeutics is currently exploring direct intracerebroventricular (ICV) administration of a proprietary formulation of an anti-epileptic drug to potentially enhance efficacy and reduce toxicity in adult patients with refractory epilepsy.

TypePrivate
Founded2010
HQAurora, US
Websitecerebraltherapeutics.com

Latest Updates

Employees (est.) (Mar 2019)2

Key People/Management at Cerebral Therapeutics

Mahendra G. Shah

Mahendra G. Shah

Director
Daniel J. Abrams

Daniel J. Abrams

CEO, Director
Stephen J. Farr

Stephen J. Farr

Director
John Foster

John Foster

President and Chief Operating Officer
Lisa Shafer

Lisa Shafer

Chief Science Officer
Eric Distad

Eric Distad

Vice President of Clinical Development
Show more

Cerebral Therapeutics Office Locations

Cerebral Therapeutics has an office in Aurora
Aurora, US (HQ)
12635 E Montview Blvd
Show all (1)

Cerebral Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2010

Cerebral Therapeutics total Funding

$10.8 m

Cerebral Therapeutics latest funding size

$7.80 m

Time since last funding

a year ago

Cerebral Therapeutics investors

Cerebral Therapeutics's latest funding round in March 2019 was reported to be $7.8 m. In total, Cerebral Therapeutics has raised $10.8 m
Show all financial metrics

Cerebral Therapeutics Online and Social Media Presence

Embed Graph

Cerebral Therapeutics News and Updates

Cerebral Therapeutics Strengthens Clinical Development Leadership with Strategic Appointments

AURORA, Colo., April 16, 2019 /PRNewswire/ -- Cerebral Therapeutics, a clinical-stage pharmaceutical company developing specialty medications for uncontrolled neurological diseases, announced today the appointments of Lisa Shafer, Ph.D., as Chief Scientific Officer, and Eric Distad as...

Cerebral Therapeutics Frequently Asked Questions

  • When was Cerebral Therapeutics founded?

    Cerebral Therapeutics was founded in 2010.

  • Who are Cerebral Therapeutics key executives?

    Cerebral Therapeutics's key executives are Mahendra G. Shah, Daniel J. Abrams and Stephen J. Farr.

  • How many employees does Cerebral Therapeutics have?

    Cerebral Therapeutics has 2 employees.

  • Who are Cerebral Therapeutics competitors?

    Competitors of Cerebral Therapeutics include Sanofi, Veloxis Pharmaceuticals and Camurus.

  • Where is Cerebral Therapeutics headquarters?

    Cerebral Therapeutics headquarters is located at 12635 E Montview Blvd, Aurora.

  • Where are Cerebral Therapeutics offices?

    Cerebral Therapeutics has an office in Aurora.

  • How many offices does Cerebral Therapeutics have?

    Cerebral Therapeutics has 1 office.